CeriBell Future Growth
Future criteria checks 2/6
CeriBell is forecast to grow earnings and revenue by 17.4% and 23.8% per annum respectively. EPS is expected to grow by 68.5% per annum. Return on equity is forecast to be -33.2% in 3 years.
Key information
17.4%
Earnings growth rate
68.5%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 23.8% |
| Future return on equity | -33.2% |
| Analyst coverage | Low |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 106 | -36 | -32 | -31 | 4 |
| 12/31/2025 | 81 | -42 | -38 | -37 | 5 |
| 12/31/2024 | 64 | -39 | -40 | -37 | 5 |
| 9/30/2024 | 60 | -36 | -34 | -32 | N/A |
| 6/30/2024 | 54 | -33 | -32 | -31 | N/A |
| 3/31/2024 | 50 | -31 | -32 | -30 | N/A |
| 12/31/2023 | 45 | -29 | -31 | -29 | N/A |
| 12/31/2022 | 26 | -37 | -33 | -32 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CBLL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CBLL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CBLL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CBLL's revenue (23.8% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: CBLL's revenue (23.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CBLL is forecast to be unprofitable in 3 years.